Completed PHASE4 INTERVENTIONAL 2-arm NCT03183765

Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts

Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts : a Randomized Controlled Trial

Sponsor: Assiut University

Conditions Common Wart Plantar Wart

Interventions Measles-Mumps-Rubella Vaccine cryotherapy

Updated 10 times since 2017 Last updated: Jun 13, 2020 Started: Aug 1, 2017 Primary completion: Mar 1, 2018 Completion: May 1, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Common Wart and Plantar Wart and is currently completed. Assiut University leads this study, which shows 10 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

10 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jul 2020 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 5 earlier versions

Jun 2020 — Jul 2020 [monthly]

Completed PHASE4

Status: Unknown Status → Completed
Jul 2019 — Jun 2020 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jun 2018 — Jul 2019 [monthly]

Recruiting PHASE4
Mar 2018 — Jun 2018 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Jul 2017 — Mar 2018 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Asyut, Egypt